HUE064642T2 - Eljárás ozanimod elõállítására - Google Patents

Eljárás ozanimod elõállítására

Info

Publication number
HUE064642T2
HUE064642T2 HUE18806925A HUE18806925A HUE064642T2 HU E064642 T2 HUE064642 T2 HU E064642T2 HU E18806925 A HUE18806925 A HU E18806925A HU E18806925 A HUE18806925 A HU E18806925A HU E064642 T2 HUE064642 T2 HU E064642T2
Authority
HU
Hungary
Prior art keywords
ozanimod
production
Prior art date
Application number
HUE18806925A
Other languages
English (en)
Inventor
Marta Porcs-Makkay
Gyula Simig
Enikoe Molnar
Janos Pethoe
Balazs Volk
Laszlo Szlavik
Eva Szabo
Judit Halasz
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of HUE064642T2 publication Critical patent/HUE064642T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/07Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HUE18806925A 2017-05-22 2018-05-18 Eljárás ozanimod elõállítására HUE064642T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUP1700216 2017-05-22

Publications (1)

Publication Number Publication Date
HUE064642T2 true HUE064642T2 (hu) 2024-04-28

Family

ID=89720175

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE18806925A HUE064642T2 (hu) 2017-05-22 2018-05-18 Eljárás ozanimod elõállítására

Country Status (12)

Country Link
US (1) US20200087269A1 (hu)
EP (1) EP3630738B1 (hu)
CN (1) CN110997645B (hu)
EA (1) EA201992421A1 (hu)
ES (1) ES2960051T3 (hu)
HR (1) HRP20231308T1 (hu)
HU (1) HUE064642T2 (hu)
MA (1) MA48798B1 (hu)
PL (1) PL3630738T3 (hu)
PT (1) PT3630738T (hu)
SI (1) SI3630738T1 (hu)
WO (1) WO2018215807A1 (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019094409A1 (en) * 2017-11-07 2019-05-16 Teva Pharmaceuticals International Gmbh Salts and solid state forms of ozanimod
EP3891133B1 (en) 2018-12-07 2023-06-07 Synthon B.V. Improved process for preparing ozanimod
WO2020152718A1 (en) * 2019-01-25 2020-07-30 Mylan Laboratories Limited Polymorphic forms 5-[3-[(1s)-2,3-dihydro-1-[(2-hydroxyethyl) amino]-1h-inden-4-yl]-1,2,4-oxadiazol-5-yl]-2-(1-methylethoxy)benzonitrile
CN112062785B (zh) * 2019-06-11 2023-06-27 广东东阳光药业有限公司 奥扎莫德及其中间体的制备方法
US20220259163A1 (en) 2019-07-16 2022-08-18 Synthon B.V. Improved process for preparing ozanimod
IL292529A (en) 2019-10-31 2022-06-01 Idorsia Pharmaceuticals Ltd Combination of cxcr7 antagonist with s1p1 receptor modulator
EP4126826A1 (en) * 2020-04-02 2023-02-08 Synthon B.V. Crystalline form of ozanimod hydrochloride
EP4212156A1 (en) 2022-01-13 2023-07-19 Abivax Combination of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine and its derivatives with a s1p receptor modulator

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2776242C (en) * 2009-10-08 2014-09-02 Sanofi Phenyloxadiazole derivatives as pgds inhibitors
EA035768B1 (ru) * 2009-11-13 2020-08-07 Селджин Интернэшнел Ii Сарл Способ получения соединения, содержащего индановую группу с хиральным атомом углерода в пятичленном кольце индановой группы
WO2015066515A1 (en) * 2013-11-01 2015-05-07 Receptos, Inc. Selective sphingosine 1 phosphate receptor modulators and combination therapy therewith
EP3470400A1 (en) * 2016-06-14 2019-04-17 Crystal Pharmaceutical (Suzhou) Co., Ltd. Crystal form of ozanimod, crystal form of hydrochloride thereof, and preparation method therefor
CN109563059A (zh) * 2016-08-19 2019-04-02 苏州科睿思制药有限公司 奥扎莫德的晶型及其制备方法
CN108137516A (zh) * 2016-09-14 2018-06-08 杭州领业医药科技有限公司 奥扎莫德的晶型、其制备方法及药物组合物
JP7086945B2 (ja) * 2016-09-29 2022-06-20 レセプトス・リミテッド・ライアビリティ・カンパニー 狼瘡を処置するための化合物および方法

Also Published As

Publication number Publication date
MA48798A (fr) 2020-04-08
ES2960051T3 (es) 2024-02-29
EP3630738B1 (en) 2023-07-19
EP3630738A1 (en) 2020-04-08
CN110997645B (zh) 2023-10-10
MA48798B1 (fr) 2023-10-31
CN110997645A (zh) 2020-04-10
SI3630738T1 (sl) 2024-02-29
PL3630738T3 (pl) 2024-04-08
WO2018215807A1 (en) 2018-11-29
HRP20231308T1 (hr) 2024-04-26
EA201992421A1 (ru) 2020-03-27
US20200087269A1 (en) 2020-03-19
PT3630738T (pt) 2023-10-24
EP3630738A4 (en) 2021-03-10

Similar Documents

Publication Publication Date Title
SG11201700367YA (en) Process for the production of cementitious material
GB2558335B (en) Novel processes for the production of oligonucleotides
GB2550003B (en) Process for the production of formaldehyde-stabilised urea
PL3201253T3 (pl) Sposób wytwarzania poliestrów
PT3630738T (pt) Processo para a produção de ozanimod
ZA201903745B (en) Process for the production of a pgm-enriched alloy
GB201721307D0 (en) Novel processes for the production of oligonucleotides
HUE053858T2 (hu) Eljárás diének elõállítására
ZA201902125B (en) Process for the production of 2-alkylalkanol
ZA201701003B (en) Process for the production of a pgm-enriched alloy
ZA201808135B (en) Process for making micro-aerated choco-material
PL3355870T3 (pl) Sposób wytwarzania kompresowanych tabletek
HUE055687T2 (hu) Eljárás D-arginil-2,6-dimetil-L-tirozil-L-lizil-L-fenilalaninamid elõállítására
PT3362405T (pt) Processo e unidade de produção para a produção de metanol
PT3182981T (pt) Processo de produção de isomaltooligosacarídeos
PL3271325T3 (pl) Sposób wytwarzania (S)-metolachloru
HUE060475T2 (hu) Eljárás izocianátok elõállítására
PL3489218T3 (pl) Sposób wytwarzania fenyloaminohydroksyantrachinonów
IL262889B (en) Process for the manufacture of 6-alkynyl-pyridine derivatives
GB2562964B (en) Process for the production of gasoline
PT3371277T (pt) Método para produzir um gás sintético.
GB201717809D0 (en) Process for the production of cobimetinib
HUE054849T2 (hu) Eljárás formaldehid-stabilizált karbamid gyártására
GB201721669D0 (en) Novel Manufacturing process
GB201708734D0 (en) Novel process